Zometa, an adjunctive breast cancer treatment

Zometa is (a necessary) evil.

I got my first infusion on Friday April 22; I had to have some IV fluids because blood work showed slight dehydration on Thursday (migraine on Wednesday = sleeping much of day = not enough fluids ingested).

Very tired on Saturday, which got more pronounced as day went on. Hit a wall at the ballet Saturday evening. Slight nausea. Chills.

Continue reading “Zometa, an adjunctive breast cancer treatment”

Lymph node transfer is a viable treatment for severe lymphedema

breast anatomy

“Cancer was a piece of cake,” Virginia Harrod says. “It was the lymphedema that almost killed me.”

NPR reports that nine months after Harrod’s mastectomy, her cat scratched her hand. She wasn’t concerned at first, but her doctor “recognized her symptoms as a serious and advancing infection.”

Harrod was in the hospital for eight days, and that’s when she first learned she had lymphedema. Over the next 10 months, she was readmitted twice more with dangerous infections.

Lymphedema (secondary/acquired) is a common complication of breast cancer treatment, but it gets short shrift from doctors when patients are assessing treatment risks. My experience confirms this research finding.

Continue reading “Lymph node transfer is a viable treatment for severe lymphedema”